{"address1": "15 Cushing", "city": "Irvine", "state": "CA", "zip": "92618", "country": "United States", "phone": "949 409 7600", "website": "https://www.oncocyte.com", "industry": "Diagnostics & Research", "industryKey": "diagnostics-research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "OncoCyte Corporation, a precision diagnostics company, focuses on development and commercialization of proprietary tests in the United States and internationally. The company is developing DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies; DetermaCNI, a blood-based monitoring tool for monitoring therapeutic efficacy in cancer patients; and VitaGraft, a blood-based solid organ transplantation monitoring test. It also provides testing services for biomarker discovery, assay design and development, clinical trial support, and various biomarker tests. The company has a collaboration agreement with Bio-Rad Laboratories, Inc. (Bio-Rad) to collaborate in the development and the commercialization of research use only and in vitro diagnostics kitted transplant products using Bio-Rad's ddPCR instruments and reagents. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.", "fullTimeEmployees": 46, "companyOfficers": [{"maxAge": 1, "name": "Mr. Joshua  Riggs", "age": 41, "title": "President, CEO & Director", "yearBorn": 1983, "fiscalYear": 2024, "totalPay": 576368, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Andrea Susan James", "age": 42, "title": "Chief Financial Officer", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 405804, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James  Liu", "age": 28, "title": "VP of Accounting, Treasurer, Senior Director, Controller & Principal Accounting Officer", "yearBorn": 1996, "fiscalYear": 2024, "totalPay": 280627, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ekkehard  Schutz M.D., Ph.D.", "title": "Chief Science Officer", "fiscalYear": 2024, "totalPay": 552014, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Yuh-Min  Chiang Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter  Hong", "title": "VP, General Counsel & Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sandra  O'Donald", "title": "Senior Vice President of Business Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Paul R. Billings FACP, M.D.", "age": 72, "title": "Consulting Chief Medical Officer", "yearBorn": 1952, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael D. West Ph.D.", "age": 71, "title": "Scientific Advisor, Co-CEO of Biotime,Inc. & President of Biotime,Inc.", "yearBorn": 1953, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.06, "open": 3.08, "dayLow": 2.8801, "dayHigh": 3.26, "regularMarketPreviousClose": 3.06, "regularMarketOpen": 3.08, "regularMarketDayLow": 2.8801, "regularMarketDayHigh": 3.26, "payoutRatio": 0.0, "beta": 0.794, "forwardPE": -1.734104, "volume": 79273, "regularMarketVolume": 79273, "averageVolume": 83446, "averageVolume10days": 54610, "averageDailyVolume10Day": 54610, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 85797904, "fiftyTwoWeekLow": 1.922, "fiftyTwoWeekHigh": 4.75, "priceToSalesTrailing12Months": 45.612923, "fiftyDayAverage": 2.81854, "twoHundredDayAverage": 2.840825, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 80825856, "profitMargins": 0.0, "floatShares": 10903477, "sharesOutstanding": 28599300, "sharesShort": 373800, "sharesShortPriorMonth": 319473, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.013099999, "heldPercentInsiders": 0.16403, "heldPercentInstitutions": 0.48098, "shortRatio": 3.11, "shortPercentOfFloat": 0.016, "impliedSharesOutstanding": 30001200, "bookValue": -0.703, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -60926000, "trailingEps": -4.66, "forwardEps": -1.73, "lastSplitFactor": "1:20", "lastSplitDate": 1690243200, "enterpriseToRevenue": 42.97, "enterpriseToEbitda": -3.728, "52WeekChange": 0.020408154, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 3.0, "targetHighPrice": 5.0, "targetLowPrice": 4.0, "targetMeanPrice": 4.41667, "targetMedianPrice": 4.25, "recommendationMean": 2.25, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 8636000, "totalCashPerShare": 0.302, "ebitda": -21683000, "totalDebt": 3664000, "quickRatio": 1.409, "currentRatio": 1.616, "totalRevenue": 1881000, "revenuePerShare": 0.144, "returnOnAssets": -0.26424, "returnOnEquity": -9.108561, "grossProfits": 828000, "freeCashflow": -14026875, "operatingCashflow": -20713000, "revenueGrowth": 3.732, "grossMargins": 0.44019002, "ebitdaMargins": 0.0, "operatingMargins": -3.64939, "financialCurrency": "USD", "symbol": "OCX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -1.9607825, "regularMarketPrice": 3.0, "marketState": "PRE", "fiftyDayAverageChange": 0.1814599, "fiftyDayAverageChangePercent": 0.06438081, "twoHundredDayAverageChange": 0.15917492, "twoHundredDayAverageChangePercent": 0.056031227, "priceToBook": -4.267425, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-03-08", "averageAnalystRating": "2.3 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1451485800000, "preMarketChange": -0.1500001, "preMarketChangePercent": -5.0000033, "preMarketPrice": 2.85, "regularMarketChange": -0.059999943, "regularMarketDayRange": "2.8801 - 3.26", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 83446, "fiftyTwoWeekLowChange": 1.078, "fiftyTwoWeekLowChangePercent": 0.56087404, "fiftyTwoWeekRange": "1.922 - 4.75", "fiftyTwoWeekHighChange": -1.75, "fiftyTwoWeekHighChangePercent": -0.36842105, "fiftyTwoWeekChangePercent": 2.0408154, "earningsTimestamp": 1742846701, "earningsTimestampStart": 1747133940, "earningsTimestampEnd": 1747656000, "earningsCallTimestampStart": 1742850000, "earningsCallTimestampEnd": 1742850000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.66, "epsForward": -1.73, "epsCurrentYear": -0.97, "priceEpsCurrentYear": -3.0927835, "corporateActions": [], "preMarketTime": 1743595803, "regularMarketTime": 1743537601, "exchange": "NCM", "messageBoardId": "finmb_78474527", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "OncoCyte Corporation", "longName": "OncoCyte Corporation", "displayName": "OncoCyte", "trailingPegRatio": null}